Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Jan 2020
Historique:
received: 05 01 2020
revised: 24 01 2020
accepted: 25 01 2020
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

Tacrolimus exhibits high inter-patient pharmacokinetics (PK) variability, as well as a narrow therapeutic index, and therefore requires therapeutic drug monitoring. Germline mutations in cytochrome P450 isoforms 4 and 5 genes (

Identifiants

pubmed: 32013193
pii: ijms21030858
doi: 10.3390/ijms21030858
pmc: PMC7037631
pii:
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 1 0
Immunosuppressive Agents 0
Cytochrome P-450 CYP3A EC 1.14.14.1
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL139730
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007149
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5T32HL007148-43
Pays : United States

Références

Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Drug Metab Dispos. 2006 May;34(5):836-47
pubmed: 16501005
J Clin Med. 2019 Nov 04;8(11):
pubmed: 31690025
Clin Pharmacol Ther. 2015 Jul;98(1):19-24
pubmed: 25801146
Br J Clin Pharmacol. 2015 Feb;79(2):222-40
pubmed: 24913012
Nephrol Dial Transplant. 2010 Aug;25(8):2757-63
pubmed: 20190242
Springer Semin Immunopathol. 2004 Nov;26(1-2):71-94
pubmed: 15549304
Bone Marrow Transplant. 2001 Oct;28(8):753-8
pubmed: 11781626
Pharmacogenetics. 2004 Mar;14(3):147-54
pubmed: 15167702
Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):546-52
pubmed: 19067682
Int J Mol Sci. 2019 May 15;20(10):
pubmed: 31096684
Transplantation. 2005 Feb 27;79(4):499-502
pubmed: 15729180
Ther Drug Monit. 2013 Oct;35(5):608-16
pubmed: 24052064
Clin Pharmacokinet. 1995 Dec;29(6):404-30
pubmed: 8787947
Pharmacogenet Genomics. 2011 Mar;21(3):152-61
pubmed: 20216335
Blood. 2012 Jan 5;119(1):296-307
pubmed: 22010102
Front Genet. 2019 Sep 26;10:871
pubmed: 31616470
Ther Drug Monit. 2009 Apr;31(2):187-97
pubmed: 19258929
Bone Marrow Transplant. 2001 Oct;28(8):737-42
pubmed: 11781624
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
BMJ Case Rep. 2013 Dec 05;2013:
pubmed: 24311415
Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
Expert Opin Drug Metab Toxicol. 2016 May;12(5):555-65
pubmed: 27010623
BMJ. 1995 Jan 21;310(6973):170
pubmed: 7833759
Bone Marrow Transplant. 2016 Apr;51(4):568-72
pubmed: 26691423
Transplant Proc. 1991 Dec;23(6):3175-8
pubmed: 1721398
Adv Drug Deliv Rev. 1997 Sep 15;27(2-3):201-214
pubmed: 10837558
Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
pubmed: 22064851
Pharmacogenet Genomics. 2012 Jul;22(7):555-8
pubmed: 22407409
Biol Blood Marrow Transplant. 2016 Feb;22(2):268-276
pubmed: 26325438
Am J Transplant. 2015 Sep;15(9):2301-13
pubmed: 26053114
Br J Haematol. 1997 Jun;97(4):855-64
pubmed: 9217189
Ther Drug Monit. 2014 Feb;36(1):71-9
pubmed: 24061445
Pharmacogenomics J. 2019 Aug;19(4):375-389
pubmed: 30442921
Clin Pharmacol Ther. 2003 Sep;74(3):245-54
pubmed: 12966368
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Bone Marrow Transplant. 2010 Oct;45(10):1540-5
pubmed: 20190848
Front Immunol. 2018 May 31;9:1184
pubmed: 29904381
Clin Pharmacokinet. 2010 Apr;49(4):207-21
pubmed: 20214406
Pharmacogenomics. 2019 Sep;20(14):1005-1020
pubmed: 31559919
Transplantation. 2002 Dec 15;74(11):1486-9
pubmed: 12490779
Haematologica. 2017 May;102(5):958-966
pubmed: 28302712
Drug Metab Pharmacokinet. 2014;29(4):341-7
pubmed: 24670405
Biol Blood Marrow Transplant. 2017 Jul;23(7):1177-1185
pubmed: 28396159
Clin Pharmacokinet. 2014 Feb;53(2):123-39
pubmed: 24249597
Nephrol Dial Transplant. 2003 May;18 Suppl 1:i12-5
pubmed: 12738758
Transplant Direct. 2017 Jan 19;3(2):e129
pubmed: 28361113
Haematologica. 2010 Jun;95(6):857-9
pubmed: 20513804
Clin Pharmacokinet. 2001;40(4):283-95
pubmed: 11368293
Biol Blood Marrow Transplant. 2019 Apr;25(4):656-663
pubmed: 30597277
J Neurol. 2018 Jul;265(7):1676-1683
pubmed: 29777361
PLoS One. 2015 Jun 03;10(6):e0127995
pubmed: 26039043
Clin Pharmacokinet. 2004;43(10):623-53
pubmed: 15244495
J Am Soc Nephrol. 2003 Jul;14(7):1889-96
pubmed: 12819250
PLoS One. 2018 Apr 5;13(4):e0191921
pubmed: 29621269
Biol Blood Marrow Transplant. 1999;5(2):94-7
pubmed: 10371361
J Clin Med. 2019 Apr 28;8(5):
pubmed: 31035422
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Transplantation. 1974 Oct;18(4):295-304
pubmed: 4153799
Pharmacogenomics. 2018 Feb;19(3):175-184
pubmed: 29318894
World J Gastroenterol. 2013 Dec 28;19(48):9156-73
pubmed: 24409044
Clin Pharmacol Ther. 2010 Jun;87(6):640-1
pubmed: 20485320
Transpl Int. 2012 Apr;25(4):471-80
pubmed: 22369694
Br J Clin Pharmacol. 2015 Oct;80(4):777-8
pubmed: 25881716
Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):311-320
pubmed: 29236211
J Heart Lung Transplant. 2011 Dec;30(12):1352-9
pubmed: 21930396
Bone Marrow Transplant. 1999 Oct;24(7):763-8
pubmed: 10516680
Clin Nutr. 2012 Oct;31(5):735-40
pubmed: 22444236
Biochem Biophys Res Commun. 2005 Dec 9;338(1):299-305
pubmed: 16171783
Pharm Res. 2009 Sep;26(9):2039-54
pubmed: 19568696
Drug Metab Dispos. 1999 Jun;27(6):633-6
pubmed: 10348790
Biol Blood Marrow Transplant. 2012 Feb;18(2):229-34
pubmed: 21708109
Pharmacogenomics J. 2015 Feb;15(1):38-48
pubmed: 25201288
Bone Marrow Transplant. 2011 Aug;46(8):1113-7
pubmed: 21102498
Clin Pharmacokinet. 2019 May;58(5):593-613
pubmed: 30415459
Eur J Clin Pharmacol. 2017 May;73(5):573-580
pubmed: 28132082
Pharmacogenet Genomics. 2016 Jan;26(1):40-3
pubmed: 26488616

Auteurs

Jing Zhu (J)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Tejendra Patel (T)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Jordan A Miller (JA)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.

Chad D Torrice (CD)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Mehak Aggarwal (M)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Margaret R Sketch (MR)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Maurice D Alexander (MD)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.
Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Paul M Armistead (PM)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

James M Coghill (JM)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Tatjana Grgic (T)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.

Katarzyna J Jamieson (KJ)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Jonathan R Ptachcinski (JR)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.
Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Marcie L Riches (ML)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Jonathan S Serody (JS)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

John L Schmitz (JL)

Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.

J Ryan Shaw (JR)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.

Thomas C Shea (TC)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Oscar Suzuki (O)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Benjamin G Vincent (BG)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

William A Wood (WA)

Division of Hematology and Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Kamakshi V Rao (KV)

Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.
Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.

Tim Wiltshire (T)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Eric T Weimer (ET)

Department of Pathology & Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.

Daniel J Crona (DJ)

The Center for Pharmacogenomics and Individualized Therapy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC 27599, USA.
Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH